Bilateral vs. Unilateral Stimulation in Neurological Bladder Disroders
NCT ID: NCT04225143
Last Updated: 2020-01-13
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
50 participants
INTERVENTIONAL
2019-11-27
2021-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Posterior Tibial Transcutaneous Neurostimulation in Idiopathic Overactive Bladder
NCT06484023
Bladder and TranscUtaneous Tibial Nerve Stimulation for nEurogenic Lower Urinary Tract Dysfunction
NCT04315142
Secondary Bilateral Sacral Nerve Stimulation in Overactive Bladder Patients
NCT01960270
Urinary Symptoms After Posterior Tibial Nerve Stimulation
NCT06458491
Study of Urgent PC Versus Sham Effectiveness in Treatment of Overactive Bladder Symptoms
NCT00771264
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The aim of this study is to evaluate the effectiveness of bilateral stimulation of the tibial nerve compared to unilateral stimulation in neurological bladder disorders.
50 patients will be included, in two arms by randomization, one arm of 25 patients will be treated by unilateral stimuylation and the other arm of 25 patients will be trated by bilateral stimulation.
They will be evaluate at 3, 6 and 12 months by auto questionnaire and the effectivess of each therapy will be compared.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
bilateral
25 patients with an overactive bladder
urostim bilateral
Treatment by bilateral neurostimulation of the tibial nerve
unilateral
25 patients with an overactive bladder
urostim unilateral
Treatment by unilateral neurostimulation of the tibial nerve
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
urostim bilateral
Treatment by bilateral neurostimulation of the tibial nerve
urostim unilateral
Treatment by unilateral neurostimulation of the tibial nerve
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Individuals affiliated to a social security scheme
* Individuals over 18 years of age
* Individuals with non-serious neurological bladder hyperactivity
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital, Caen
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
CHU Caen Normandie
Caen, , France
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
UROSTIM
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.